Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Using Multiparametric Magnetic Resonance Imaging to Shift Prostate Cancer Diagnosis Toward Clinically Significant Disease and Minimize Overdiagnosis (and Overtreatment).

Henry A.

Int J Radiat Oncol Biol Phys. 2019 Dec 1;105(5):915-917. doi: 10.1016/j.ijrobp.2019.09.040. Review. No abstract available.

PMID:
31748142
2.

Defining a Cohort that May Not Require Repeat Prostate Biopsy Based on PCA3 Score and Magnetic Resonance Imaging: The Dual Negative Effect.

Perlis N, Al-Kasab T, Ahmad A, Goldberg E, Fadak K, Sayyid R, Finelli A, Kulkarni G, Hamilton R, Zlotta A, Ghai S, Fleshner N.

J Urol. 2018 May;199(5):1182-1187. doi: 10.1016/j.juro.2017.11.074. Epub 2017 Nov 23. Erratum in: J Urol. 2018 Sep;200(3):660.

PMID:
29175542
3.

Reducing Unnecessary Prostate Multiparametric Magnetic Resonance Imaging by Using Clinical Parameters to Predict Negative and Indeterminate Findings.

Deniffel D, Zhang Y, Salinas E, Satkunasivam R, Khalvati F, Haider MA.

J Urol. 2020 Feb;203(2):292-298. doi: 10.1097/JU.0000000000000518. Epub 2019 Sep 3.

PMID:
31479397
4.

Role of magnetic resonance imaging in defining a biopsy strategy for detection of prostate cancer.

Ridout AJ, Kasivisvanathan V, Emberton M, Moore CM.

Int J Urol. 2014 Jan;21(1):5-11. doi: 10.1111/iju.12259. Epub 2013 Sep 3. Review.

5.

Which Patients with Negative Magnetic Resonance Imaging Can Safely Avoid Biopsy for Prostate Cancer?

Oishi M, Shin T, Ohe C, Nassiri N, Palmer SL, Aron M, Ashrafi AN, Cacciamani GE, Chen F, Duddalwar V, Stern MC, Ukimura O, Gill IS, Luis de Castro Abreu A.

J Urol. 2019 Feb;201(2):268-276. doi: 10.1016/j.juro.2018.08.046.

6.

Negative Predictive Value of Prostate Multiparametric Magnetic Resonance Imaging among Men with Negative Prostate Biopsy and Elevated Prostate Specific Antigen: A Clinical Outcome Retrospective Cohort Study.

Lo G, Burton KR, Haider MA, Fleshner N, Finelli A, Ghai S.

J Urol. 2019 Dec;202(6):1159-1165. doi: 10.1097/JU.0000000000000388. Epub 2019 Jun 12.

PMID:
31188731
7.

Integration of multiparametric MRI into active surveillance of prostate cancer.

Holtz JN, Tay KJ, Polascik TJ, Gupta RT.

Future Oncol. 2016 Nov;12(21):2513-2529. Epub 2016 Jun 20. Review.

PMID:
27322161
8.

Diagnostic Accuracy of Multiparametric Magnetic Resonance Imaging and Fusion Guided Targeted Biopsy Evaluated by Transperineal Template Saturation Prostate Biopsy for the Detection and Characterization of Prostate Cancer.

Mortezavi A, Märzendorfer O, Donati OF, Rizzi G, Rupp NJ, Wettstein MS, Gross O, Sulser T, Hermanns T, Eberli D.

J Urol. 2018 Aug;200(2):309-318. doi: 10.1016/j.juro.2018.02.067. Epub 2018 Feb 21.

PMID:
29474846
9.

Prostate MRI can reduce overdiagnosis and overtreatment of prostate cancer.

Rosenkrantz AB, Taneja SS.

Acad Radiol. 2015 Aug;22(8):1000-6. doi: 10.1016/j.acra.2015.02.006. Epub 2015 Mar 17. Review.

PMID:
25791578
10.

Comparison of Prostate Biopsy with or without Prebiopsy Multiparametric Magnetic Resonance Imaging for Prostate Cancer Detection: An Observational Cohort Study.

Bryant RJ, Hobbs CP, Eyre KS, Davies LC, Sullivan ME, Shields W, Sooriakumaran P, Verrill CL, Gleeson FV, MacPherson RE, Hamdy FC, Brewster SF.

J Urol. 2019 Mar;201(3):510-519. doi: 10.1016/j.juro.2018.09.049.

PMID:
30266332
11.

Comparison of Transrectal Ultrasound Biopsy to Transperineal Template Mapping Biopsies Stratified by Multiparametric Magnetic Resonance Imaging Score in the PROMIS Trial.

Lovegrove CE, Miah S, El-Shater Bosaily A, Bott S, Brown L, Burns-Cox N, Dudderidge T, Freeman A, Henderson A, Hindley R, Kaplan R, Kirkham A, Oldroyd R, Parker C, Persad R, Punwani S, Rosario D, Shergill I, Winkler M, Emberton M, Ahmed HU.

J Urol. 2020 Jan;203(1):100-107. doi: 10.1097/JU.0000000000000455. Epub 2019 Jul 23.

PMID:
31335254
12.

Magnetic Resonance-Guided Prostate Biopsy.

Dianat SS, Carter HB, Macura KJ.

Magn Reson Imaging Clin N Am. 2015 Nov;23(4):621-31. doi: 10.1016/j.mric.2015.05.005. Epub 2015 Jul 9. Review.

PMID:
26499279
13.

When to Order an MRI in the Initial Evaluation and Management of Prostate Cancer.

Walton-Diaz A, Rais-Bahrami S.

Oncology (Williston Park). 2018 Oct 15;32(10):501-4.

14.

Magnetic Resonance Imaging-Ultrasound Fusion Targeted Prostate Biopsy in a Consecutive Cohort of Men with No Previous Biopsy: Reduction of Over Detection through Improved Risk Stratification.

Mendhiratta N, Rosenkrantz AB, Meng X, Wysock JS, Fenstermaker M, Huang R, Deng FM, Melamed J, Zhou M, Huang WC, Lepor H, Taneja SS.

J Urol. 2015 Dec;194(6):1601-6. doi: 10.1016/j.juro.2015.06.078. Epub 2015 Jun 19.

PMID:
26100327
15.

The roles of multiparametric magnetic resonance imaging, PCA3 and prostate health index-which is the best predictor of prostate cancer after a negative biopsy?

Porpiglia F, Russo F, Manfredi M, Mele F, Fiori C, Bollito E, Papotti M, Molineris I, Passera R, Regge D.

J Urol. 2014 Jul;192(1):60-6. doi: 10.1016/j.juro.2014.01.030. Epub 2014 Feb 8.

16.

Utility of multiparametric magnetic resonance imaging suspicion levels for detecting prostate cancer.

Rais-Bahrami S, Siddiqui MM, Turkbey B, Stamatakis L, Logan J, Hoang AN, Walton-Diaz A, Vourganti S, Truong H, Kruecker J, Merino MJ, Wood BJ, Choyke PL, Pinto PA.

J Urol. 2013 Nov;190(5):1721-1727. doi: 10.1016/j.juro.2013.05.052. Epub 2013 May 29.

17.
18.

The Efficacy of Multiparametric Magnetic Resonance Imaging and Magnetic Resonance Imaging Targeted Biopsy in Risk Classification for Patients with Prostate Cancer on Active Surveillance.

Recabal P, Assel M, Sjoberg DD, Lee D, Laudone VP, Touijer K, Eastham JA, Vargas HA, Coleman J, Ehdaie B.

J Urol. 2016 Aug;196(2):374-81. doi: 10.1016/j.juro.2016.02.084. Epub 2016 Feb 23.

19.

Usefulness of pre-biopsy multiparametric magnetic resonance imaging and clinical variables to reduce initial prostate biopsy in men with suspected clinically localized prostate cancer.

Numao N, Yoshida S, Komai Y, Ishii C, Kagawa M, Kijima T, Yokoyama M, Ishioka J, Matsuoka Y, Koga F, Saito K, Masuda H, Fujii Y, Kawakami S, Kihara K.

J Urol. 2013 Aug;190(2):502-8. doi: 10.1016/j.juro.2013.02.3197. Epub 2013 Mar 7.

PMID:
23473904
20.

High diagnostic ability of multiparametric magnetic resonance imaging to detect anterior prostate cancer missed by transrectal 12-core biopsy.

Komai Y, Numao N, Yoshida S, Matsuoka Y, Nakanishi Y, Ishii C, Koga F, Saito K, Masuda H, Fujii Y, Kawakami S, Kihara K.

J Urol. 2013 Sep;190(3):867-73. doi: 10.1016/j.juro.2013.03.078. Epub 2013 Mar 28.

PMID:
23542406

Supplemental Content

Support Center